Primary pulmonary hypertension: survival benefits of therapy with prostacyclin analogs and transplantation

Transplant Proc. 2003 Sep;35(6):2117-20. doi: 10.1016/s0041-1345(03)00750-4.

Authors

M Dandel¹, D Kemper, Y Weng, M Hummel, S Mulahasanovic, S Kapell, H Lehmkuhl, R Hetzer

Affiliation

¹ Department of Cardiothoracic and Vascular Surgery Deutsches Herzzentrum Berlin, Berlin, Germany. dandel@dhzb.de

PMID: 14529860
DOI: 10.1016/s0041-1345(03)00750-4

No abstract available

MeSH terms

Heart Transplantation / mortality
Heart Transplantation / physiology*
Heart-Lung Transplantation / mortality
Heart-Lung Transplantation / physiology
Humans
Hypertension, Pulmonary / drug therapy
Hypertension, Pulmonary / mortality*
Hypertension, Pulmonary / surgery*
Prostaglandins / therapeutic use
Retrospective Studies
Survival Analysis

Substances

Prostaglandins